The Limitations of Laboratory Medicine with relevance to Biomarker tests and Global organ disease

Research output: Contribution to conferenceAbstract

Abstract

Various diagnostic technologies have been used with relevance to genomics, lipidomics and proteomics to allow more sensitive interpretations with relevance to early cell dysfunction. The diagnostic technologies encompass the genome, transcriptome, proteome and metabolome (central dogma of biology, Wikipedia) and determine the cell genome (nuclear receptors) and transcription factor alterations with relevance to concentrations of plasma lipids and proteins. The projected cost of plasma and cell biomarker analysis is expected to be by the year 2020 approximately 52 billion dollars. Major efforts with biomarkers have been identified with plasma protein panels to assess progression and severity of diseases. In spite of laboratory medicine and various analyte measurements for chronic diseases early abnormal nuclear-mitochondria interactions have not been identified with toxic immune reactions involved in mitochondrial apoptosis and the induction of programmed cell death.
Original languageEnglish
Publication statusPublished - 25 Jun 2018
Event13th International Conference on Laboratory Medicine and Pathology - Berlin, Germany
Duration: 25 Jun 201826 Jun 2018

Conference

Conference13th International Conference on Laboratory Medicine and Pathology
CountryGermany
CityBerlin
Period25/06/1826/06/18

Fingerprint

Blood Proteins
Biomarkers
Medicine
Genome
Technology
Metabolome
Poisons
Proteome
Cytoplasmic and Nuclear Receptors
Genomics
Plasma Cells
Transcriptome
Proteomics
Disease Progression
Mitochondria
Chronic Disease
Cell Death
Transcription Factors
Apoptosis
Lipids

Cite this

Martins, I. (2018). The Limitations of Laboratory Medicine with relevance to Biomarker tests and Global organ disease. Abstract from 13th International Conference on Laboratory Medicine and Pathology, Berlin, Germany.
Martins, Ian. / The Limitations of Laboratory Medicine with relevance to Biomarker tests and Global organ disease. Abstract from 13th International Conference on Laboratory Medicine and Pathology, Berlin, Germany.
@conference{277cb5864a424676a3cc0df83fcd78ff,
title = "The Limitations of Laboratory Medicine with relevance to Biomarker tests and Global organ disease",
abstract = "Various diagnostic technologies have been used with relevance to genomics, lipidomics and proteomics to allow more sensitive interpretations with relevance to early cell dysfunction. The diagnostic technologies encompass the genome, transcriptome, proteome and metabolome (central dogma of biology, Wikipedia) and determine the cell genome (nuclear receptors) and transcription factor alterations with relevance to concentrations of plasma lipids and proteins. The projected cost of plasma and cell biomarker analysis is expected to be by the year 2020 approximately 52 billion dollars. Major efforts with biomarkers have been identified with plasma protein panels to assess progression and severity of diseases. In spite of laboratory medicine and various analyte measurements for chronic diseases early abnormal nuclear-mitochondria interactions have not been identified with toxic immune reactions involved in mitochondrial apoptosis and the induction of programmed cell death.",
author = "Ian Martins",
year = "2018",
month = "6",
day = "25",
language = "English",
note = "13th International Conference on Laboratory Medicine and Pathology ; Conference date: 25-06-2018 Through 26-06-2018",

}

Martins, I 2018, 'The Limitations of Laboratory Medicine with relevance to Biomarker tests and Global organ disease' 13th International Conference on Laboratory Medicine and Pathology, Berlin, Germany, 25/06/18 - 26/06/18, .

The Limitations of Laboratory Medicine with relevance to Biomarker tests and Global organ disease. / Martins, Ian.

2018. Abstract from 13th International Conference on Laboratory Medicine and Pathology, Berlin, Germany.

Research output: Contribution to conferenceAbstract

TY - CONF

T1 - The Limitations of Laboratory Medicine with relevance to Biomarker tests and Global organ disease

AU - Martins, Ian

PY - 2018/6/25

Y1 - 2018/6/25

N2 - Various diagnostic technologies have been used with relevance to genomics, lipidomics and proteomics to allow more sensitive interpretations with relevance to early cell dysfunction. The diagnostic technologies encompass the genome, transcriptome, proteome and metabolome (central dogma of biology, Wikipedia) and determine the cell genome (nuclear receptors) and transcription factor alterations with relevance to concentrations of plasma lipids and proteins. The projected cost of plasma and cell biomarker analysis is expected to be by the year 2020 approximately 52 billion dollars. Major efforts with biomarkers have been identified with plasma protein panels to assess progression and severity of diseases. In spite of laboratory medicine and various analyte measurements for chronic diseases early abnormal nuclear-mitochondria interactions have not been identified with toxic immune reactions involved in mitochondrial apoptosis and the induction of programmed cell death.

AB - Various diagnostic technologies have been used with relevance to genomics, lipidomics and proteomics to allow more sensitive interpretations with relevance to early cell dysfunction. The diagnostic technologies encompass the genome, transcriptome, proteome and metabolome (central dogma of biology, Wikipedia) and determine the cell genome (nuclear receptors) and transcription factor alterations with relevance to concentrations of plasma lipids and proteins. The projected cost of plasma and cell biomarker analysis is expected to be by the year 2020 approximately 52 billion dollars. Major efforts with biomarkers have been identified with plasma protein panels to assess progression and severity of diseases. In spite of laboratory medicine and various analyte measurements for chronic diseases early abnormal nuclear-mitochondria interactions have not been identified with toxic immune reactions involved in mitochondrial apoptosis and the induction of programmed cell death.

M3 - Abstract

ER -

Martins I. The Limitations of Laboratory Medicine with relevance to Biomarker tests and Global organ disease. 2018. Abstract from 13th International Conference on Laboratory Medicine and Pathology, Berlin, Germany.